About Actin-like protein 7B
Actin-like protein 7B (ACTL7B) is a protein
from Homo sapiens identified by UniProt accession
Q9Y614, 415 residues long.
MolForge cross-references it against 0 known binders and
144 disease associations.
Target properties
| Protein name | Actin-like protein 7B |
| UniProt accession | Q9Y614 |
| Gene | ACTL7B |
| Organism | Homo sapiens |
| Length | 415 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (144)
Diseases linked to this target (Open Targets).
- heel bone mineral density · score 0.33
- balding measurement · score 0.32
- hair shape measurement · score 0.28
- neurofibrillary tangles measurement · score 0.22
- keratoconus · score 0.22
- central corneal thickness · score 0.22
- bone quantitative ultrasound measurement · score 0.22
- adolescent idiopathic scoliosis · score 0.13
- lobe attachment · score 0.13
- facial morphology measurement · score 0.12
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9Y614-F1 | alphafold | PREDICTED | 87.92 | — |
Amino-acid sequence (415 residues)
MATRNSPMPL GTAQGDPGEA GTRPGPDASL RDTGAATQLK MKPRKVHKIK AVIIDLGSQY CKCGYAGEPR PTYFISSTVG KRCPEAADAG DTRKWTLVGH ELLNTEAPLK LVNPLKHGIV VDWDCVQDIW EYIFRTAMKI LPEEHAVLVS DPPLSPSSNR EKYAELMFET FGIPAMHVTS QSLLSIYSYG KTSGLVVESG HGVSHVVPIS EGDVLPGLTS RADYAGGDLT NYLMQLLNEA GHAFTDDHLH IIEHIKKKCC YAAFLPEEEL GLVPEELRVD YELPDGKLIT IGQERFRCSE MLFQPSLAGS TQPGLPELTA ACLGRCQDTG FKEEMAANVL LCGGCTMLDG FPERFQRELS LLCPGDSPAV AAAPERKTSV WTGGSILASL QAFQQLWVSK EEFEERGSVA IYSKC
Explore Actin-like protein 7B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets